Cytogenetic characteristics of t-MDS and t-AML after autologous stem cell transplantation—review of the literature
| Cytogenetics . | t-MDS (no. of patients) . | t-AML (no. of patients) . |
|---|---|---|
| Normal | 4 | — |
| 1 Aberration | 21 | 8 |
| 2-3 Aberrations | 14 | 4 |
| 4-5 Aberrations | 7 | — |
| >5 Aberrations | 17 | — |
| Total | 63 | 12 |
| −5 or del(5q) | 26 | 4 |
| −7 or del(7q) | 28 | 5 |
| −17 or del(17p) | 5 | — |
| del(20q) | 9 | — |
| Balanced transl. to 11q23 | 2 | 33-150 |
| Balanced transl. to 21q22 | 3 | 3 |
| Other unspecific balanced | 13 | — |
| t(9;22) | 1 | 13-151 |
| Cytogenetics . | t-MDS (no. of patients) . | t-AML (no. of patients) . |
|---|---|---|
| Normal | 4 | — |
| 1 Aberration | 21 | 8 |
| 2-3 Aberrations | 14 | 4 |
| 4-5 Aberrations | 7 | — |
| >5 Aberrations | 17 | — |
| Total | 63 | 12 |
| −5 or del(5q) | 26 | 4 |
| −7 or del(7q) | 28 | 5 |
| −17 or del(17p) | 5 | — |
| del(20q) | 9 | — |
| Balanced transl. to 11q23 | 2 | 33-150 |
| Balanced transl. to 21q22 | 3 | 3 |
| Other unspecific balanced | 13 | — |
| t(9;22) | 1 | 13-151 |